Brind.

Jazz Pharmaceuticals stock declined 11% on July 8, 2025, while the S&P 500 saw a gain of 5.3%.

1 report, 0 independent Updated Jul 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Jazz Pharmaceuticals

Keep exploring

The entities involved

Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
- Multiple financial firms adjusted their holdings in Jazz Pharmaceuticals stock and filed reports with the SEC on October 24, 2026.Sat 14:00
- Jazz Pharmaceuticals plans U.S. launch of Ziihera.Fri 16:12

Coverage

Newest first; wire copies grouped

Jul 8Unknown outlet